Effect of an investigational vaccine for preventing Staphylococcus aureus infections after cardiothoracic surgery: a randomized trial.
about
Current controversies in infective endocarditisInvestigational drugs to treat methicillin-resistant Staphylococcus aureusStaphylococcal manipulation of host immune responsesWill there ever be a universal Staphylococcus aureus vaccine?Adult vaccinationWhere does a Staphylococcus aureus vaccine stand?Vaccines for the 21st centuryNeutrophil-Mediated Phagocytosis of Staphylococcus aureusUse of surveillance data to identify target populations for Staphylococcus aureus vaccines and prevent surgical site infections: a pilot study.Humanized Mouse Models of Staphylococcus aureus Infection.Vaccines for Acinetobacter baumannii: thinking "out of the box".Epic Immune Battles of History: Neutrophils vs. Staphylococcus aureus.Zero tolerance for healthcare-associated MRSA bacteraemia: is it realistic?Microbiota-driven immune cellular maturation is essential for antibody-mediated adaptive immunity to Staphylococcus aureus infection in the eye.Applying Convergent Immunity to Innovative Vaccines Targeting Staphylococcus aureus.The staphylococcal toxins γ-haemolysin AB and CB differentially target phagocytes by employing specific chemokine receptorsPassive immunization with anti-glucosaminidase monoclonal antibodies protects mice from implant-associated osteomyelitis by mediating opsonophagocytosis of Staphylococcus aureus megaclusters.Lysibodies are IgG Fc fusions with lysin binding domains targeting Staphylococcus aureus wall carbohydrates for effective phagocytosis.Antibodies to Staphylococcus aureus serotype 8 capsular polysaccharide react with and protect against serotype 5 and 8 isolatesVaccine protection of leukopenic mice against Staphylococcus aureus bloodstream infectionStaphylococcus aureus Infections After Elective Cardiothoracic Surgery: Observations From an International Randomized Placebo-Controlled Trial of an Investigational S aureus VaccineProtein A suppresses immune responses during Staphylococcus aureus bloodstream infection in guinea pigs.Active immunization with an octa-valent Staphylococcus aureus antigen mixture in models of S. aureus bacteremia and skin infection in miceIdentification of the immunodominant regions of Staphylococcus aureus fibronectin-binding protein A.Vaccine composition formulated with a novel TLR7-dependent adjuvant induces high and broad protection against Staphylococcus aureusMemory Th1 Cells Are Protective in Invasive Staphylococcus aureus Infection.Iron acquisition in the cystic fibrosis lung and potential for novel therapeutic strategies.Differential Interaction of the Staphylococcal Toxins Panton-Valentine Leukocidin and γ-Hemolysin CB with Human C5a ReceptorsEfficacy profile of a bivalent Staphylococcus aureus glycoconjugated vaccine in adults on hemodialysis: Phase III randomized study.Safety and immunogenicity of an investigational 4-component Staphylococcus aureus vaccine with or without AS03B adjuvant: Results of a randomized phase I trial.Proteomic Identification of saeRS-Dependent Targets Critical for Protective Humoral Immunity against Staphylococcus aureus Skin InfectionPrevention of Recurrent Staphylococcal Skin InfectionsMF59- and Al(OH)3-Adjuvanted Staphylococcus aureus (4C-Staph) Vaccines Induce Sustained Protective Humoral and Cellular Immune Responses, with a Critical Role for Effector CD4 T Cells at Low Antibody Titers.Adaptive designs from a Data Safety Monitoring Board perspective: Some controversies and some case studies.CCR-2 neutralization augments murine fresh BMC activation by Staphylococcus aureus via two distinct mechanisms: at the level of ROS production and cytokine response.Innate Immune Signaling Activated by MDR Bacteria in the AirwayPreclinical Efficacy of Clumping Factor A in Prevention of Staphylococcus aureus Infection.Protective efficacy of the chimeric Staphylococcus aureus vaccine candidate IC in sepsis and pneumonia modelsAntibody-Based Biologics and Their Promise to Combat Staphylococcus aureus Infections.Exploiting dominant-negative toxins to combat Staphylococcus aureus pathogenesis
P2860
Q26766194-D4A80D83-44CF-40DE-A051-0702C5A6FB5FQ26780246-58A039E6-6818-4284-B03D-0E6A9C0C8885Q26798461-3347ADAC-6406-4A04-9BC9-2D4FDDF772F9Q26824837-04378EC5-4B33-4EC1-AADF-0502983D7DDEQ26824961-82B9F8AF-6366-4B88-83A0-A88E558ABF40Q26828726-E51D9107-FCC4-411E-802B-26A0A061DB5CQ27007529-B8241227-6229-4026-9A86-E2DDB1D62185Q27025128-A3DDCDCE-FDBB-4CF3-8190-654892DE0C9DQ30890973-272ED3EF-2408-4526-84B5-B52ABD89E2ECQ33634034-3B127468-921C-47A5-BED4-790D9A98279EQ33637895-A9C65A22-8C8B-4B74-BA0A-BC5E00F4186BQ33854487-4791AECA-1109-4BD8-A708-A25AA0CDCF18Q33910015-1383B2FE-AA59-4688-8226-EE79EAB4955FQ34059043-D7322096-9B42-4C3B-96E6-46F0EB58ECC4Q34250054-D83C17D5-1106-423F-BC86-6D8577A49411Q34495209-E349232C-34AD-4037-94CE-561B517A6AE0Q34522708-6DC191C6-E62F-4A22-9D5D-E26D675B7B59Q34555552-BC1522AB-FEC1-4EE6-B840-0A860C965467Q34595644-E45468F4-9B77-4D9A-8B77-536AD39F26CFQ34596203-0D8CC283-95E7-4B74-BFBD-1F8D34CC1876Q34801828-FACA93D7-A6DD-4321-8129-604FCB8794CBQ35038206-CC3A7D11-C5F7-4668-A2FF-E84D312700F1Q35116935-A8144A6D-F96B-46B3-8BCC-974A0E9AF086Q35149380-449F9649-95F2-492B-A1D0-FEE57FDFBB80Q35229369-5134FA5E-8FFB-4473-A974-A74DC65A28F7Q35833250-CA38C6D7-46E2-4E46-8D98-11313A36FF58Q35862783-01424650-0760-4B43-BACA-8FFE01CA96E3Q35864500-1F81FEBD-6B19-4FC7-A2F5-3C7012433C77Q35887127-C2CD1BBA-B8F4-4F92-99FF-3B8E0CCDFF04Q35887417-4AD3AE88-F68F-4062-8628-7C828AE7C414Q35947359-5B01F611-CAD8-4E1B-981A-FE63FF9C8EC2Q36005464-F7FEC73D-5A65-4DE1-AADE-2659FD07D8A2Q36032570-E8B6949F-A2D1-432F-9BB2-A0C193FAE251Q36274426-AC1AD485-3744-450E-8AA2-DA08755AEECDQ36346773-6522D6BF-2E9F-44CC-A47E-1A1272118B02Q36422470-E98D3D57-7031-46E6-B741-522E0B67406CQ36548288-DB9689BF-9BB2-41A0-922B-CD4A9E588EABQ36569841-83339BB1-AB04-49DE-ADFB-68633763A58FQ36609408-B305FD2F-6B4D-4115-A5DE-BE6002C647A0Q36636170-71482F3B-4054-4F3B-829B-0E63AC7FB25E
P2860
Effect of an investigational vaccine for preventing Staphylococcus aureus infections after cardiothoracic surgery: a randomized trial.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Effect of an investigational v ...... c surgery: a randomized trial.
@en
type
label
Effect of an investigational v ...... c surgery: a randomized trial.
@en
prefLabel
Effect of an investigational v ...... c surgery: a randomized trial.
@en
P2093
P356
P1476
Effect of an investigational v ...... c surgery: a randomized trial.
@en
P2093
Ajoke Sobanjo-ter Meulen
Dalya Guris
Edson D Moreira
Frank Isgro
G Ralph Corey
Helen W Boucher
Ivan S F Chan
Jonathan S Hartzel
Keith B Allen
Mark J DiNubile
P304
P356
10.1001/JAMA.2013.3010
P407
P577
2013-04-01T00:00:00Z